Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Excitatory amino acids in epilepsy.

E M Urbanska1, S J Czuczwar, Z Kleinrok

  • 1Department of Pharmacology and Toxicology, University Medical School, Jaczewskiego 8, PL-20-090, Lublin, Poland. ewau@galen.imw.lublin.pl

Restorative Neurology and Neuroscience
|April 3, 2003
PubMed
Summary

This review explores glutamate's role in epilepsy. Glutamate receptor modulators show promise as anticonvulsants, offering potential new treatments for this neurological disorder.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurological effects of acute exposure to caffeine and organophosphates in mice.

Polish journal of veterinary sciences·2021
Same author

The in vitro effect of kynurenic acid on the rainbow trout (Oncorhynchus mykiss) leukocyte and splenocyte activity.

Polish journal of veterinary sciences·2014
Same author

Quinolinate-like neurotoxicity produced by aminooxyacetic acid in rat striatum.

Amino acids·2013
Same author

Tryptophan-kynurenine metabolism and insulin resistance in hepatitis C patients.

Hepatitis research and treatment·2013
Same author

Micromolar concentration of kynurenic acid in rat small intestine.

Amino acids·2008
Same author

Interactions between tiagabine and conventional antiepileptic drugs in the rat model of complex partial seizures.

Journal of neural transmission (Vienna, Austria : 1996)·2008

Area of Science:

  • Neuroscience
  • Neurology
  • Pharmacology

Background:

  • Epilepsy affects approximately 0.5% of the population, characterized as a neurological disorder.
  • Excitatory glutamatergic transmission significantly contributes to seizure initiation, propagation, and maintenance.
  • Alterations in glutamate concentration and receptor function are observed in epileptic patients.

Purpose of the Study:

  • To review the involvement of excitatory amino acid receptors in seizures and epilepsy.
  • To summarize findings from human and animal studies on glutamatergic mechanisms in epilepsy.
  • To explore the potential therapeutic role of targeting glutamatergic pathways for epilepsy treatment.

Main Methods:

  • Review of existing literature on glutamate and epilepsy.

Related Experiment Videos

  • Analysis of studies involving glutamate receptor agonists and antagonists in animal seizure models.
  • Examination of data from human studies on glutamate receptor function in epilepsy.

    • Main Results:

    • Glutamate plays a critical role in the development and progression of epileptic activity.
    • Glutamate receptor agonists can induce seizures in experimental models.
    • Glutamate antagonists demonstrate significant anticonvulsant properties across various seizure models.

    Conclusions:

    • Glutamatergic mechanisms are central to understanding epilepsy.
    • Targeting ionotropic and metabotropic glutamate receptors presents a promising therapeutic avenue for epilepsy.
    • Further research is needed to define the clinical application of glutamatergic drugs in epilepsy management.